Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 18Liver Neoplasms 9Colorectal Neoplasms 6Cholangiocarcinoma 4Rupture, Spontaneous 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Colonic Neoplasms 2Tissue Adhesions 1Sarcopenia 1Postoperative Complications 1Neoplasms 1Long-term Effects of Cancer Treatment 1Liver Surgery 1Hemangioma 1Focal Nodular Hyperplasia 1Conversion Disorder 1Colorectal Cancer Metastatic 1

Interventions

Gemcitabine 358Fluorouracil 94Oxaliplatin 81Capecitabine 74130-nm albumin-bound paclitaxel 71Albumin-Bound Paclitaxel 70Radiotherapy 67Leucovorin 58Irinotecan 49Erlotinib Hydrochloride 47Cisplatin 44Bevacizumab 31pembrolizumab 30Radiosurgery 30Docetaxel 26Taxes 24Nivolumab 24Cetuximab 24Pancreaticoduodenectomy 20Drug Therapy 17folfirinox 16Cyclophosphamide 16Radiation 15Ipilimumab 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 13Surgical Procedures, Operative 12Sorafenib 12Paclitaxel 12Neoadjuvant Therapy 12irinotecan sucrosofate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pancreatic Neoplasms × Hepatectomy × Clear all
NCT06980792 2025-05-20

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Azienda Ospedaliero-Universitaria di Modena

Completed
90 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT03801915 2023-03-21

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡